#151244

Anti-Cdk2 [AN4.3]

Cat. #151244

Anti-Cdk2 [AN4.3]

Cat. #: 151244

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 1-2 weeks

Target: Cyclin-dependent kinase 2 (cdk2)

Class: Monoclonal

Application: ELISA ; FACS ; IP ; WB

Reactivity: Human ; Mouse ; Xenopus laevis

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Julian Gannon

Institute: Cancer Research UK, London Research Institute: Clare Hall Laboratories

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-Cdk2 [AN4.3]
  • Alternate name: Cyclin-Dependent Kinase 2; Cell Division Protein Kinase 2; P33 Protein Kinase; CDKN2; CDC2-Related Protein Kinase; P33(CDK2)
  • Clone: AN4.3
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human ; Mouse ; Xenopus laevis
  • Host: Mouse
  • Application: ELISA ; FACS ; IP ; WB
  • Description: Cdk2 is a cell cycle protein closely related to Cdk1 (Cdc2) and a useful marker of proliferation. Cdk2 binds cyclins A and E and controls progression into S-phase.
  • Immunogen: Human recombinant Cdk2
  • Isotype: IgG2a
  • Myeloma used: Sp2/0-Ag14

Target Details

  • Target: Cyclin-dependent kinase 2 (cdk2)
  • Target background: Cdk2 is a cell cycle protein closely related to Cdk1 (Cdc2) and a useful marker of proliferation. Cdk2 binds cyclins A and E and controls progression into S-phase.

Applications

  • Application: ELISA ; FACS ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C

References

  • Syafrizayanti et al. 2017. Sci Rep. 7:39756. PMID: 28045055.
  • Personalised proteome analysis by means of protein microarrays made from individual patient samples.
  • Chang et al. 2016. J Formos Med Assoc. :. PMID: 27773559.
  • Immunophenotypic and genetic characteristics of diffuse large B-cell lymphoma in Taiwan.
  • Chu et al. 2016. Journal of Fn Foods. 23:614-627
  • Xu et al. 2010. Biol Pharm Bull. 33(5):743-51. PMID: 20460749.
  • Targeting the Na(+)/K(+)-ATPase alpha1 subunit of hepatoma HepG2 cell line to induce apoptosis and cell cycle arresting.
  • Ottewell et al. 2009. Mol Cancer Ther. 8(10):2821-32. PMID: 19789217.
  • Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone.